Effects of simvastatin on retinoic acid system in primary human endometrial stromal cells and in a chimeric model of human endometriosis

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 3, 2013, Pages

  Sokalska, Anna ^a,b,c   Anderson, MariaPia ^a   Villanueva, Jesus ^a   Ortega, Israel ^a,d   Bruner Tran, Kaylon L ^e   Osteen, Kevin G ^e   Duleba, Antoni J ^a,f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d IVI Madrid   (Spain)

^e VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CASPASE 3; CASPASE 7; CELLULAR RETINOIC ACID BINDING PROTEIN 2; FATTY ACID BINDING PROTEIN 5; RETINOIC ACID; RETINOL; RNA; SIMVASTATIN; STIMULATED BY RETINOIC ACID 6 PROTEIN; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DISEASE MODEL; ENDOMETRIOSIS; ENDOMETRIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN TRANSPORT; REAL TIME POLYMERASE CHAIN REACTION; STROMA CELL; WESTERN BLOTTING;

ADULT; ANIMALS; APOPTOSIS; CELL PROLIFERATION; CELL SURVIVAL; CHIMERA; DISEASE MODELS, ANIMAL; ENDOMETRIOSIS; ENDOMETRIUM; FATTY ACID-BINDING PROTEINS; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MEMBRANE PROTEINS; MICE; MICE, NUDE; NEOPLASM PROTEINS; PRIMARY CELL CULTURE; RECEPTORS, RETINOIC ACID; SIMVASTATIN; STROMAL CELLS; TRETINOIN;

EID: 84874888466     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-3402     Document Type: Article

References (37)

1. Rombouts K, Kisanga E, Hellemans K, Wielant A, Schuppan D, Geerts A. Effect of HMG-CoA reductase inhibitors on proliferation and protein synthesis by rat hepatic stellate cells. J Hepatol. 2003;38:564-572. (Pubitemid 36560640)
2. Danesh FR, Sadeghi MM, Amro N, et al. 3-Hydroxy-3-methylglutaryl CoA reductase inhibitors prevent high glucose-induced proliferation of mesangial cells via modulation of Rho GTPase/p21 signaling pathway: implications for diabetic nephropathy. Proc Natl Acad Sci USA. 2002;99:8301-8305. (Pubitemid 34651047)
3. Mattingly RR, Gibbs RA, Menard RE, Reiners JJ Jr. Potent suppression of proliferation of a10 vascular smooth muscle cells by combined treatment with lovastatin and 3-allylfarnesol, an inhibitor of protein farnesyltransferase. J Pharmacol Exp Ther. 2002;303: 74-81.
4. Piotrowski PC, Kwintkiewicz J, Rzepczynska IJ, et al. Statins inhibit growth of human endometrial stromal cells independently of cholesterol availability. Biol Reprod. 2006;75:107-111. (Pubitemid 43946345)
5. Sokalska A, Wong DH, Cress A, et al. Simvastatin induces apoptosis and alters cytoskeleton in endometrial stromal cells. J Clin Endocrinol Metab. 2010;95:3453-3459.
6. Esfandiari N, Khazaei M, Ai J, et al. Effect of a statin on an in vitro model of endometriosis. Fertil Steril. 2007;87:257-262. (Pubitemid 46188442)
7. Nasu K, Yuge A, Tsuno A, Narahara H. Simvastatin inhibits the proliferation and the contractility of human endometriotic stromal cells: a promising agent for the treatment of endometriosis. Fertil Steril. 2009;92:2097-2099.
8. Sharma I, Dhawan V, Mahajan N, Chand Saha S, Dhaliwal LK. In vitro effects of atorvastatin on lipopolysaccharide-induced gene expression in endometriotic stromal cells. Fertil Steril. 2009;94(5): 1639-46.e1.
9. Bruner-Tran KL, Osteen KG, Duleba AJ. Simvastatin protects against the development of endometriosis in a nude mouse model. J Clin Endocrinol Metab. 2009;94:2489-2494.
10. Oktem M, Esinler I, Eroglu D, Haberal N, Bayraktar N, Zeyneloglu HB. High-dose atorvastatin causes regression of endometriotic implants: a rat model. Hum Reprod. 2007;22:1474-1480. (Pubitemid 47062821)
11. Yilmaz B, Ozat M, Kilic S, et al. Atorvastatin causes regression of endometriotic implants in a rat model. Reprod Biomed Online. 2010;20:291-299.
12. Bruner-Tran KL, Webster-Clair D, Osteen KG. Experimental endometriosis: the nude mouse as a xenographic host. Ann NY Acad Sci. 2002;955:328-339; discussion 340-342, 396-406. (Pubitemid 34271090)
13. Zheng WL, Ong DE. Spatial and temporal patterns of expression of cellular retinol-binding protein and cellular retinoic acid-binding proteins in rat uterus during early pregnancy. Biol Reprod. 1998;58:963-970. (Pubitemid 28144984)
14. Zheng WL, Sierra-Rivera E, Luan J, Osteen KG, Ong DE. Retinoic acid synthesis and expression of cellular retinol-binding protein and cellular retinoic acid-binding protein type II are concurrent with decidualization of rat uterine stromal cells. Endocrinology. 2000;141:802-808. (Pubitemid 32250506)
15. Sidell N, Feng Y, Hao L, et al. Retinoic acid is a cofactor for translational regulation of vascular endothelial growth factor in human endometrial stromal cells. Mol Endocrinol. 2010;24:148-160.
16. Wu J, Hansen JM, Hao L, Taylor RN, Sidell N. Retinoic acid stimulation of VEGF secretion from human endometrial stromal cells is mediated by production of reactive oxygen species. J Physiol. 2011;589:863-875.
17. Pavone ME, Dyson M, Reirstad S, et al. Endometriosis expresses a molecular pattern consistent with decreased retinoid uptake, metabolism and action. Hum Reprod. 2011;26:2157-2164.
18. Pavone ME, Reierstad S, Sun H, Milad M, Bulun SE, Cheng YH. Altered retinoid uptake and action contributes to cell survival in endometriosis. J Clin Endocrinol Metab. 2010;95:E300-E309.
19. Schug TT, Berry DC, Shaw NS, Travis SN, Noy N. Opposing effects of retinoic acid on cell growth result from alternate activation of two different nuclear receptors. Cell. 2007;129:723-733. (Pubitemid 46802374)
20. Arici A, Head JR, MacDonald PC, Casey ML. Regulation of interleukin- 8 gene expression in human endometrial cells in culture. Mol Cell Endocrinol. 1993;94:195-204. (Pubitemid 23246244)
21. Krikun G, Hu Z, Osteen K, et al. The immunoconjugate "icon" targets aberrantly expressed endothelial tissue factor causing regression of endometriosis. Am J Pathol. 2010;176:1050-1056.
22. Bruner-Tran KL, Eisenberg E, Yeaman GR, Anderson TA, McBean J, Osteen KG. Steroid and cytokine regulation of matrix metalloproteinase expression in endometriosis and the establishment of experimental endometriosis in nude mice. J Clin Endocrinol Metab. 2002;87:4782-4791. (Pubitemid 35247076)
23. Wieser F, Wu J, Shen Z, Taylor RN, Sidell N. Retinoic acid suppresses growth of lesions, inhibits peritoneal cytokine secretion, and promotes macrophage differentiation in an immunocompetent mouse model of endometriosis. Fertil Steril. 2012;97(6):1430-1437.
24. Hoang TC, Bui TK, Taguchi T, Watanabe T, Sato Y. All-trans retinoic acid inhibits KIT activity and induces apoptosis in gastrointestinal stromal tumor GIST-T1 cell line by affecting on the expression of survivin and Bax protein. J Exp Clin Cancer Res. 2010;29:165.
25. Jiang M, Zhu K, Grenet J, Lahti JM. Retinoic acid induces caspase-8 transcription via phospho-CREB and increases apoptotic responses to death stimuli in neuroblastoma cells. Biochim Biophys Acta. 2008;1783:1055-1067.
26. Karabulut B, Karaca B, Varol U, et al. Enhancing cytotoxic and apoptotic effect in OVCAR-3 and MDAH-2774 cells with all-trans retinoic acid and zoledronic acid: a paradigm of synergistic molecular targeting treatment for ovarian cancer. J Exp Clin Cancer Res. 2010;29:102.
27. Kucukzeybek Y, Gul MK, Cengiz E, et al. Enhancement of docetaxel-induced cytotoxicity and apoptosis by all-trans retinoic acid (ATRA) through downregulation of survivin (BIRC5), MCL-1 and LTβ-R in hormone- and drug-resistant prostate cancer cell line, DU-145. J Exp Clin Cancer Res. 2008;27:37.
28. Vertuani S, Dubrovska E, Levitsky V, Jager MJ, Kiessling R, Levitskaya J. Retinoic acid elicits cytostatic, cytotoxic and immunomodulatory effects on uveal melanoma cells. Cancer Immunol Immunother. 2007;56:193-204. (Pubitemid 44833093)
29. Zhang H, Satyamoorthy K, Herlyn M, Rosdahl I. All-trans retinoic acid (atRA) differentially induces apoptosis in matched primary and metastatic melanoma cells-a speculation on damage effect of at RA via mitochondrial dysfunction and cell cycle redistribution. Carcinogenesis. 2003;24:185-191. (Pubitemid 36267085)
30. Karabulut B, Karaca B, Atmaca H, et al. Regulation of apoptosisrelated molecules by synergistic combination of all-trans retinoic acid and zoledronic acid in hormone-refractory prostate cancer cell lines. Mol Biol Rep. 2011;38:249-259.
31. Kawaguchi R, Yu J, Honda J, et al. A membrane receptor for retinol binding protein mediates cellular uptake of vitamin A. Science (New York, NY). 2007;315:820-825.
32. Dimitroulakos J, Yeger H. HMG-CoA reductase mediates the biological effects of retinoic acid on human neuroblastoma cells: lovastatin specifically targets P-glycoprotein-expressing cells. Nat Med. 1996;2:326-333. (Pubitemid 26082012)
33. McTaggart SJ. Isoprenylated proteins. Cell Mol Life Sci. 2006;63: 255-267. (Pubitemid 43202309)
34. Bergstrom JD, Bostedor RG, Rew DJ, Geissler WM, Wright SD, Chao YS. Hepatic responses to inhibition of 3-hydroxy-3-methylglutaryl- CoA reductase: a comparison of atorvastatin and simvastatin. Biochim Biophys Acta. 1998;1389:213-221. (Pubitemid 28097321)
35. Conde K, Roy S, Freake HC, Newton RS, Fernandez ML. Atorvastatin and simvastatin have distinct effects on hydroxy methylglutaryl- CoA reductase activity and mRNA abundance in the guinea pig. Lipids. 1999;34:1327-1332. (Pubitemid 30044272)
36. Green JR, Clezardin P. Mechanisms of bisphosphonate effects on osteoclasts, tumor cell growth, and metastasis. Am J Clin Oncol. 2002;25:S3-S9. (Pubitemid 35453651)
37. Goffinet M, Thoulouzan M, Pradines A, et al. Zoledronic acid treatment impairs protein geranyl-geranylation for biological effects in prostatic cells. BMC Cancer. 2006;6:60.